Consensus Incyte Corporation

Equities

INCY

US45337C1027

Market Closed - Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
56.97 USD -0.26% Intraday chart for Incyte Corporation -0.02% -9.27%

Evolution of the average Target Price on Incyte Corporation

Price target over the last 5 years

History of analyst recommendation changes

8552551fac806.rFYtQxjKir26ricnk2vE67oVlb-AFyzoghun3S_HXec.7Q9gBS-D7tHcwklIpCf838JS0ejneFaR9mHpkEujNZbaHnl2cIDB8OmeYg~3fd73209943f78e01a88279d6c3d2f92
Jefferies Initiates Incyte With Buy Rating, Price Target is $81 MT
BMO Capital Adjusts Price Target on Incyte to $64 From $58, Keeps Market Perform Rating MT
Citigroup Adjusts Price Target on Incyte to $81 From $82, Keeps Buy Rating MT
JMP Securities Downgrades Incyte to Market Perform From Market Outperform MT
Truist Securities Adjusts Price Target on Incyte to $84 From $91, Maintains Buy Rating MT
Stifel Adjusts Price Target on Incyte to $68 From $67, Maintains Hold Rating MT
The market faces a choice Our Logo
RBC Lifts PT on Incyte to $65 From $63 on Model Updates Reflecting Monjuvi Integration, Slightly Improved Jakafi/Opzelura Sales Expectations; Sector Perform Kept MT
ANALYST RECOMMENDATIONS : Biogen, Gsk, Hp Inc, Palantir, Walt Disney... Our Logo
Mizuho Adjusts Incyte's Price Target to $77 From $82, Keeps Neutral Rating MT
Leerink Partners Upgrades Incyte to Outperform From Market Perform, Raises Price Target to $78 From $63 MT
Guggenheim Upgrades Incyte to Buy From Neutral, Price Target is $86 MT
Goldman Sachs Downgrades Incyte to Neutral From Buy, Cuts Price Target to $65 From $98 MT
Goldman Sachs Adjusts Price Target on Incyte to $98 From $114, Keeps Buy Rating MT
Morgan Stanley Cuts Incyte Price Target to $64 From $74, Maintains Equal Weight Rating MT
RBC Cuts Price Target on Incyte to $63 From $74, Notes Weaker-Than-Expected Q3 Sales, Keeps Sector Perform Rating MT
ANALYST RECOMMENDATIONS : Best Buy, Easyjet, Fortinet, Tesla, Netflix... Our Logo
ANALYST RECOMMENDATIONS : Biogen, Glencore, Home Depot, Meta Platforms, On Semi... Our Logo
Stifel Adjusts Incyte's Price Target to $76 From $73, Keeps Hold Rating MT
BMO Capital Trims Price Target on Incyte to $68 From $70, Maintains Market Perform Rating MT
Truist Securities Adjusts Price Target on Incyte to $91 From $100, Maintains Buy Rating MT
RBC Raises Price Target on Incyte to $73 From $70, Cites 'Solid Quarter,' Maintains Sector Perform Rating MT
Citigroup Initiates Incyte With Buy Rating, $82 Price Target MT
ANALYST RECOMMENDATIONS : Walmart, Nike, Progressive, Domino's Pizza, Coinbase, Capital One... Our Logo
BofA Securities Downgrades Incyte to Neutral From Buy, Adjusts Price Target to $84 From $93 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
56.97 USD
Average target price
76.01 USD
Spread / Average Target
+33.42%
High Price Target
92 USD
Spread / Highest target
+61.49%
Low Price Target
58 USD
Spread / Lowest Target
+1.81%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Incyte Corporation

Jefferies & Co.
BMO Capital
Citigroup
JMP Securities
Truist Securities
Stifel Nicolaus
RBC Capital Markets
Mizuho Securities
SVB Securities LLC
Guggenheim
Goldman Sachs
Morgan Stanley
BofA Securities
Morningstar
TD Cowen
Oppenheimer
Cowen
Evercore ISI
Piper Sandler
Wells Fargo Securities
JPMorgan Chase
SVB Leerink
Benchmark Capital
Credit Suisse
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings